Owing to its high specificity and affinity in liver cancer cells, monoclonal antibody AFP (antiAFPMcAb) can be used to carry various “warheads” such as chemotherapy agent, radioactive nuclide or toxin to selectively attack AFP-positive cancer cells64, 65. This evidence concerns the gene AFP and liver cancer.